Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

DNTH

Dianthus Therapeutics, Inc. /DE/

Pharmaceutical Preparations · SIC 2834CIK 1690585Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$2.0M
Net Income FY2025
$(162.0M)
EPS (Basic, as reported)
$-4.20
Net Margin FY2025
-7973.3%
ROE FY2025
-32.9%
Total Equity
$493.0M
Shares Out
56M
Business description

Dianthus Therapeutics, Inc. /DE/ — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 2
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023⚑FY2024FY2025
Revenue0000———362
Research & development(6)(28)(41)(59)(51)(47)(55)(33)(83)(146)
General & administrative(3)(8)(19)(24)(28)(28)(26)(18)(25)(34)
Total operating expenses(9)(36)(60)(83)(79)(75)(81)(51)(108)(180)
Operating income(9)(36)(60)(83)(79)(75)(81)(48)(102)(178)
Interest expense0—————————
Interest & investment income———————31110
Other income (expense), net002———151716
Income tax expense0000000000
Net income(9)(35)(58)(77)(75)(71)(76)(44)(85)(162)
EPS — basic————($1.71)($1.29)($1.29)($8.45)($2.55)($4.20)
EPS — diluted————($1.71)($1.29)($1.29)($8.45)($2.55)($4.20)
Shares outstanding — basic (M)————44555953339
Shares outstanding — diluted (M)————44555953339
  • ⚑ Weighted-average shares changed ÷12.50 between FY2022 and FY2023 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×6.60 between FY2023 and FY2024 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.